Verity - Hiv News

Crime & justice

Science & technology

Environment/energy

Bias Split Public Figures Controversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

How our sliders work About Contact Us Newsletter Archive

HIV

The U.S. Food and Drug Administration (FDA) approved Lenacapavir — a twice-yearly injectable drug to prevent HIV — on Wednesday, with manufacturer Gilead Sciences marketing it under the brand name Yeztugo.

FDA Approves Biannual HIV Prevention Shot

Study: Highly-Affordable 'Vaccine-Like' HIV Drug Possible

JUL 23 2024JUL 2024

UN: AIDS Response 'Under Threat' Due to Stigmas

NOV 28 2023NOV 2023

Scientists Cut Out HIV DNA From Infected Cells

MAR 20 2024MAR 2024

FDA Finalizes New Blood Donation Guidelines

MAY 11 2023MAY 2023